project id: TCGA-STAD; case submitter id: TCGA-IN-A6RI; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.91; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.51; rna integrity number: 8.3; age at index: 45; days to birth: -16788; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1967; age at diagnosis: 16788; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage I; ajcc pathologic t: T1b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 559.0; icd 10 code: C16.0; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cardia, NOS; synchronous malignancy: No; tissue or organ of origin: Cardia, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 482; initial weight: 270.0; sample id: 815db115-54ed-43ad-9da8-0b1efa93374a; sample submitter id: TCGA-IN-A6RI-01A; portion id: e1ea1e95-dacd-4403-983f-307896ad376d; portion submitter id: TCGA-IN-A6RI-01A-11; slide id: cacc8d66-4b7c-403c-8a7f-1eb646916669; slide submitter id: TCGA-IN-A6RI-01A-01-TS1; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 5.0; percent necrosis: 17.0; percent neutrophil infiltration: 5.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 83.0; percent tumor nuclei: 70.0; section location: TOP;